OPENBAARMAKING IN OVEREENSTEMMING MET ARTIKEL 14 VAN DE BELGISCHE WET VAN 2 MEI 2007 BETREFFENDE DE OPENBAARMAKING VAN BELANGRIJKE DEELNEMINGEN (DE "TRANSPARANTIEWET")
March 20, 2018 02:01 ET
|
Ablynx NV
GEREGLEMENTEERDE INFORMATIE GENT, België, 20 maart 2018 - Ablynx [Euronext Brussels en Nasdaq: ABLX] maakte vandaag bekend, in overeenstemming met artikel 14 van de Belgische wet van 2 mei 2007...
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
March 20, 2018 02:01 ET
|
Ablynx NV
REGULATED INFORMATION GHENT, Belgium, 20 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the...
ABLYNX KONDIGT UITOEFENING WARRANTS AAN
March 15, 2018 02:01 ET
|
Ablynx NV
GEREGLEMENTEERDE INFORMATIE GENT, België, 15 maart 2018 - Ablynx [Euronext Brussels en Nasdaq: ABLX] kondigde vandaag aan, in overeenstemming met titel II van de Wet van 2 mei 2007 en het...
ABLYNX ANNOUNCES WARRANT EXERCISE
March 15, 2018 02:01 ET
|
Ablynx NV
REGULATED INFORMATION GHENT, Belgium, 15 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14...
OPENBAARMAKING IN OVEREENSTEMMING MET ARTIKEL 14 VAN DE BELGISCHE WET VAN 2 MEI 2007 BETREFFENDE DE OPENBAARMAKING VAN BELANGRIJKE DEELNEMINGEN (DE "TRANSPARANTIEWET")
March 12, 2018 02:01 ET
|
Ablynx NV
GEREGLEMENTEERDE INFORMATIE GENT, België, 12 maart 2018 - Ablynx [Euronext Brussels en Nasdaq: ABLX] maakte vandaag bekend, in overeenstemming met artikel 14 van de Belgische wet van 2 mei 2007...
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
March 12, 2018 02:01 ET
|
Ablynx NV
REGULATED INFORMATION GHENT, Belgium, 12 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the...
OPENBAARMAKING IN OVEREENSTEMMING MET ARTIKEL 14 VAN DE BELGISCHE WET VAN 2 MEI 2007 BETREFFENDE DE OPENBAARMAKING VAN BELANGRIJKE DEELNEMINGEN (DE "TRANSPARANTIEWET")
March 09, 2018 01:01 ET
|
Ablynx NV
GEREGLEMENTEERDE INFORMATIE GENT, België, 9 maart 2018 - Ablynx [Euronext Brussels en Nasdaq: ABLX] maakte vandaag bekend, in overeenstemming met artikel 14 van de Belgische wet van 2 mei 2007...
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
March 09, 2018 01:01 ET
|
Ablynx NV
REGULATED INFORMATION GHENT, Belgium, 9 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the...
ABLYNX START DOSERING IN HAAR FASE II STUDIE MET ALX-0171 IN GEHOSPITALISEERDE JAPANSE BABY'S MET EEN RSV INFECTIE
March 02, 2018 01:01 ET
|
Ablynx NV
GENT, België, 2 maart 2018 - Ablynx [Euronext Brussels en Nasdaq: ABLX] deelde vandaag mee dat de eerste patiënt gedoseerd werd in de Japanse Fase II studie met ALX-0171, de Vennootschap's...
ABLYNX COMMENCES DOSING IN ITS PHASE II STUDY OF ALX-0171 IN HOSPITALISED JAPANESE INFANTS WITH A RSV INFECTION
March 02, 2018 01:01 ET
|
Ablynx NV
GHENT, Belgium, 2 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced that the first patient has been dosed in the Japanese Phase II study of ALX-0171, the Company's wholly-owned...